<DOC>
	<DOC>NCT01439295</DOC>
	<brief_summary>Urinary ascorbyl peroxide level in the first week of life will be a good predictor of Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.</brief_summary>
	<brief_title>Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia</brief_title>
	<detailed_description>This study uses ascorbyl peroxide as representative of oxidative stress in premature infants on parenteral nutrition and aims to test the correlation of this metabolite and the different major neonatal outcomes 'mainly bronchopulmonary dysplasia).</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<criteria>Preterm infants less than 33 weeks of gestation&lt; Admission to CHU SainteJUstien neonatal intensive care unit Receiving Parenteral nutrition during the first week of life Parental consent Major congenital anomalies Sever perinatal asphyxia</criteria>
	<gender>All</gender>
	<minimum_age>23 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Ascorbyl peroxide</keyword>
	<keyword>Bronchopulmonary dysplasia</keyword>
	<keyword>Redox status</keyword>
	<keyword>Necrotising entercolitis</keyword>
	<keyword>Retinopathy of prematurity</keyword>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Intraventricular hemorrhage</keyword>
	<keyword>Periventricular leucomalacia</keyword>
</DOC>